NosoVeille Août 2011 - NosoBase

| | |
|[pic] |NosoVeille n°8 |
| | |
| |Août 2016 |
[pic] Ce bulletin de veille est une publication mensuelle qui recueille les
publications scientifiques publiées au cours du mois écoulé. Il est disponible sur le site de NosoBase à l'adresse suivante :
http://www.cclin-arlin.fr/nosobase
Pour recevoir, tous les mois, NosoVeille dans votre messagerie :
Abonnement / Désabonnement
[pic] Sommaire de ce numéro : Anesthésie
Animal
Antibiotique/Antibiorésistance
Antiseptique
Bactériémie
Biofilm
Chirurgie
Clostridium difficile
Ebola
EMS
Endoscopie
Environnement
Epidémie
Fish therapy
Grippe
Hygiène des mains
Infection urinaire
Maternité
Pédiatrie
Personnel
Pneumonie
Soin intensif
Stérilisation
Urgence
Usager
Zika Anesthésie NosoBase ID notice : 415769
Le risque de maladie infectieuse associée à la contamination de propofol Zorrilla-Vaca A; Arevalo J; Escandón-Vargas K; Soltanifar D; Mirski MA.
Infectious disease risk associated with contaminated propofol anesthesia,
1989-2014. Emerging infectious diseases 2016/06; 22 (6): 981-992. Mots-clés : ANESTHESIE; TRANSMISSION; CONTAMINATION; INFECTION; INFECTION
NOSOCOMIALE; REVUE DE LA LITTERATURE; PROPOFOL Administration of propofol, the most frequently used intravenous
anesthetic worldwide, has been associated with several iatrogenic
infections despite its relative safety. Little is known regarding the
global epidemiology of propofol-related outbreaks and the effectiveness of
existing preventive strategies. In this overview of the evidence of
propofol as a source of infection and appraisal of preventive strategies,
we identified 58 studies through a literature search in PubMed, Embase, and
Lilacs for propofol-related infections during 1989-2014. Twenty propofol-
related outbreaks have been reported, affecting 144 patients and resulting
in 10 deaths. Related factors included reuse of syringes for multiple
patients and prolonged exposure to the environment when vials were left
open. The addition of antimicrobial drugs to the emulsion has been
instituted in some countries, but outbreaks have still occurred. There
remains a lack of comprehensive information on the effectiveness of
measures to prevent future outbreaks.
Animal NosoBase ID notice : 416845
La prévention de l'infection transmise lors d'un programme de zoothérapie :
un exemple Hardin P; Brown J; Wright ME. Prevention of transmitted infections in a pet
therapy program: An exemplar. American journal of infection control
2016/07; 44 (7): 846-850. Mots-clés : PREVENTION; ANIMAL; INFECTION; RECOMMANDATIONS DE BONNE
PRATIQUE The focus of the patient experience in health care delivery has afforded
the opportunity to integrate pet therapy as a part of patient care. The
purpose of this article is to present the implementation of a pet therapy
program that includes guidelines for the prevention of transmitted
infections. Consideration of infection prevention strategies has resulted
in a 16-year program with no documented incidences of transmitted
infections, averaging 20,000 pet therapy interactions per year.
Antibiotique/Antibiorésistance NosoBase ID notice : 416211
Colonisation à Entérobactéries résistant aux céphalosporines de troisième
génération lors de l'admission à l'hôpital : prévalence et facteur de
risque Hamprecht A; Rohde AM; Behnke M; Feihl S; Gastmeier P; Gebhardt F; et al.
Colonization with third-generation cephalosporin-resistant
Enterobacteriaceae on hospital admission: prevalence and risk factors.
Journal of antimicrobial chemotherapy 2016/06/17; in press : 1-7. Mots-clés : ENTEROBACTERIE; ANTIBIORESISTANCE; CEPHALOSPORINE TROISIEME
GENERATION; ADMISSION; PREVALENCE; FACTEUR DE RISQUE Objectives: The objectives of this study were to prospectively assess the
rectal carriage rate of third-generation cephalosporin-resistant
Enterobacteriaceae (3GCREB) in non-ICU patients on hospital admission and
to investigate resistance mechanisms and risk factors for carriage.
Methods: Adult patients were screened for 3GCREB carriage at six German
tertiary care hospitals in 2014 using rectal swabs or stool samples. 3GCREB
isolates were characterized by phenotypic and molecular methods. Each
patient answered a questionnaire about potential risk factors for
colonization with MDR organisms (MDROs). Univariable and multivariable risk
factor analyses were performed to identify factors associated with 3GCREB
carriage.
Results: Of 4376 patients, 416 (9.5%) were 3GCREB carriers. Escherichia
coli was the predominant species (79.1%). ESBLs of the CTX-M-1 group
(67.3%) and the CTX-M-9 group (16.8%) were the most frequent ?-lactamases.
Five patients (0.11%) were colonized with carbapenemase-producing
Enterobacteriaceae. The following risk factors were significantly
associated with 3GCREB colonization in the multivariable analysis (P